Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

Fewer Pathologists and More Cancer Patients Drive Pathology Market

By HospiMedica International staff writers
Posted on 02 Jan 2018
The global digital pathology market was worth USD 381.8 million in 2016 and is projected to grow at a CAGR of 13.2% to reach USD 708.9 million by 2021, driven by the increased adoption of digital pathology solutions worldwide due to shortage of pathologists and rise in new cancer cases. More...
Additionally, new business models and increased FDA approvals of Whole Slide Image (WSI) scanners for primary diagnostics are expected to provide a boost to the digital pathology market.

These are the findings of Frost & Sullivan, a consulting and research firm (Santa Clara, CA, USA).

The declining number of pathologists and increase in procedural volumes due to a rise in the number of oncology cases is expected to be a key growth driver of the digital pathology market. The World Health Organization (WHO) estimates a rise of about 70% in the number of new cases over the next two decades. Digital pathology is known to enhance the productivity of pathologists by 10% to 15%, leading to an improvement in the overall efficiency of healthcare providers. Digital pathology solutions are well suited for oncology care and are useful in cancer diagnosis, as these systems allow physicians to quickly take and consider a second opinion in critical cases. Additionally, the use of digital pathology in drug discovery allows pharmaceutical companies to remove bias and provide quantifiable results.

The growing applications of digital pathology in drug development activities, increasing awareness, and FDA approval for the use of digital pathology systems in clinical applications are expected to further fuel the growth of the digital pathology market. Digital pathology devices were not approved for primary diagnosis until Philips received approval for Intellisite in April 2017, which is likely to drive higher adoption of digital pathology in primary diagnosis. Further approvals of WSIs anticipated over the next 3 to 5 years will lead to increased competition in the digital pathology market.

The share of the software segment in the digital pathology market is estimated to increase on account of an expected increase in spending on image processing and analysis software products. Moreover, increased focus on using machine learning tools and Artificial Intelligence- (AI) based algorithm for automated predictive healthcare solutions will provide a boost to the spending on software solutions.

Since machine learning and AI-based platforms enable useful clinical interpretation of whole slide images, companies are strongly focusing on developing new algorithms and updating their existing ones. Multi-spectral imaging in whole slide scanning also provides a significant growth opportunity as the capabilities to handle multiple staining using multi-spectral imaging systems allow pathologists to more accurately probe the tissue biomarkers. Hence, multi-spectral imaging in whole slide scanning holds significant growth potential due to its high adoption in the clinical segment.

In spite of the higher efficiency and clinical effectiveness of digital pathology solutions, their high cost remains one of the key restraints to market growth, especially among small-to-mid-sized laboratories. However, new business models and partnerships among vendors are expected to change this scenario in the future.

“Strategic partnerships will be essential to pushing market growth. Vendors who provide one or two components for the entire digital pathology portfolio will need to identify the right partner to devise a more robust and complete offering,” said Divyaa Ravishankar, Senior Research Analyst at Frost & Sullivan. “Additionally, vendors should also be able to provide the laboratories with a portfolio of business models.”

Related Links:
Frost & Sullivan


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Fetal Monitor
BT-380
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.